Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability. [electronic resource]
Producer: 19990922Description: 1708-14 p. digitalISSN:- 1078-0432
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.